Turning groundbreaking biotech research into real-world solutions is often hindered by the infamous “valley of death” — the critical gap where funding is scarce, risk is high, and startups often fail to take shape. We will explore how the venture builder model can play a transformative role in bridging that gap and accelerating the path from lab bench to market.
In this session, we will discover:
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
Great networking and learning opportunities to share knowledge with colleagues from their various areas of expertise.
Bruno Woeran
Merinova OY - TII President, Finland
This course gives an in-depth understanding on managing contract portfolio, including research contracts, license agreements, and other collaboration agreements.
Ram Siddappa
Erasmus MC, Netherlands
Recent studies on both sides of the Atlantic, directed by either ASTP or AUTM, demonstrate the tremendous economic and societal benefit and value technology transfer has brought us.
Koenraad Debackere
KU Leuven, Belgium
A lot of fruitful discussions with experienced peers. Very helpful sessions.
Sara Matt-Leubner
University of Innsbruck, Austria
The event had something to offer all members of the TT community from entry level to mid-career and beyond.
John Gleeson
University of Limerick, Ireland
Join our newsletter and get the latest news